京新药业(002020)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002020 京新药业

已收盘 10-12 15:00:00

{"stockData":{"symbol":"002020","market":"SZ","secType":"STK","nameCN":"京新药业","latestPrice":11.7,"timestamp":1791788583000,"preClose":11.87,"halted":0,"volume":14669400,"delay":0,"changeRate":-0.0143,"floatShares":724000000,"shares":861000000,"eps":0.8383,"marketStatus":"已收盘","change":-0.17,"latestTime":"10-12 15:00:00","open":11.91,"high":12.02,"low":11.65,"amount":173000000,"amplitude":0.0312,"askPrice":11.71,"askSize":506,"bidPrice":11.7,"bidSize":105,"shortable":0,"etf":0,"ttmEps":0.8383,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.87,"symbolType":"stock","openAndCloseTimeList":[[1791768600000,1791775800000],[1791781200000,1791788400000]],"highLimit":13.06,"lowLimit":10.68,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":861029140,"isCdr":false,"pbRate":1.7,"roa":"--","peRate":13.956817,"roe":"5.78%","epsLYR":0.92,"committee":0.011791,"marketValue":10074000000,"turnoverRate":0.0203,"status":1,"floatMarketCap":8470000000},"requestUrl":"/m/hq/s/002020/","defaultTab":"news","newsList":[{"id":"2674876349","title":"京新药业：回购股份比例达1.02% 累计耗资1.10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876349","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876349?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:43","pubTimestamp":1791798180,"startTime":"0","endTime":"0","summary":"10月12日，京新药业(002020.SZ)公告称，公司拟使用自有资金以集中竞价方式回购股份用于注销并减少注册资本，回购总金额不低于1亿元、不超过2亿元，回购价格不超过19元/股，回购实施期限自20 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261012/c680599613.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261012/c680599613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674004866","title":"股市必读：京新药业新发布《关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674004866","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674004866?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:37","pubTimestamp":1791481028,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，京新药业报收于11.7元，下跌1.1%，换手率2.99%，成交量21.64万手，成交额2.57亿元。公司公告汇总：截至2026年9月30日，京新药业已回购股份708.93万股，占总股本0.82%，成交总金额8995.6921万元，回购进展符合方案要求。公司公告汇总关于股份回购进展公告浙江京新药业股份有限公司于2026年7月2日召开第九届董事会第五次会议，2026年7月20日召开2026年第二次临时股东会，审议通过《关于回购公司股份用于注销并减少注册资本的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900001814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018774","title":"京新药业：截至9月30日公司回购股份708.93万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018774","media":"同花顺","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673018774?lang=zh_cn&edition=full","pubTime":"2026-10-07 20:32","pubTimestamp":1791376320,"startTime":"0","endTime":"0","summary":"    证券日报网讯 10月7日，京新药业发布公告称，截至2026年9月30日，公司通过股份回购专用证券账户以集中竞价方式回购公司股份708.93万股，占公司总股本的0.82% ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261007/c680448637.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261007/c680448637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["002020","SURE","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671269050","title":"京新药业（002020）9月28日主力资金净卖出1210.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671269050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671269050?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:08","pubTimestamp":1790644129,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，京新药业报收于11.35元，上涨0.89%，换手率1.68%，成交量12.15万手，成交额1.37亿元。近5日资金流向一览见下表：京新药业融资融券信息显示，融资方面，当日融资买入1098.91万元，融资偿还1587.89万元，融资净偿还488.99万元。京新药业主营业务：化学制剂、传统中药、生物制剂、化学原料药、医疗器械的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446362","title":"京新药业二度递表港交所：高溢价关联收购后遗症显现 实控人5年拿走7亿后又向市场要钱","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446362","media":"新浪证券","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669446362?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:38","pubTimestamp":1790239080,"startTime":"0","endTime":"0","summary":"高溢价关联收购后遗症显现 账上现金充裕仍赴港募资除了业务方面面临的挑战之外，京新药业在公司治理层面同样存在隐忧。2021年底，京新药业以2.05亿元收购实控人吕钢旗下的广东沙溪制药100%股权，全部对价以上市公司自有资金支付。截至2026年上半年，京新药业货币资金、交易性金融资产及各期限定期存单构成的类现金资产规模超过23亿元，同期有息负债仅约2亿元。仅现金分红一项，实控人体系每年即可稳定获得超1亿元的现金回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-24/doc-inisxnuz4956180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002020","IPOS","HEXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669566456","title":"京新药业：公司盐酸卡立派嗪在国内属于首家上市，属于仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2669566456","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669566456?lang=zh_cn&edition=full","pubTime":"2026-09-24 11:36","pubTimestamp":1790221001,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，京新药业盐酸卡利哌嗪同是购买匈牙利配方专利，艾伯雄为啥叫原研药，京新药业盐酸卡利哌嗪就叫仿制药？29年一月一日专利到期，两年我们也该叫原研药，为啥我们自降身份呢？京新药业回复：您好！公司盐酸卡立派嗪在国内属于首家上市，属于仿制药，符合国内的相关政策，公司会积极推进盐酸卡立哌嗪的销售工作，尽快给公司贡献收入。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400016902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669565574","title":"京新药业：深圳巨烽经营稳定，业绩稳定增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2669565574","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669565574?lang=zh_cn&edition=full","pubTime":"2026-09-24 11:36","pubTimestamp":1790221001,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：问吕董，公司子公司深圳巨烽做为医疗器械显示器方面的龙头对比市场上五州医疗、采纳服你等等，无论营收还是净利润都远远比不上深圳巨烽而它们的市值确高达近百亿，几乎赶上京新药业母公市值，如此为何母公司不引入战投，分拆上市。做大做强。京新药业回复：您好！谢谢您的建议，目前深圳巨烽经营稳定，业绩稳定增长，公司会综合考虑其未来发展的方向。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400016906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669610171","title":"京新药业再度向港交所递交上市申请 中信证券独家保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2669610171","media":"观点地产网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669610171?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:32","pubTimestamp":1790001120,"startTime":"0","endTime":"0","summary":"观点网讯：9月18日，京新药业向港交所主板递交上市申请，中信证券为其独家保荐人。京新药业是一家A股上市逾20年的制药企业，此次为其二度冲刺港股。此前其于2026年2月首次递表，后因6个月有效期届满而失效。免责声明：本文内容与数据由观点根据公开信息整理，不构成投资建议，使用前请核实。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/estate/integration/2026-09-21/doc-inisrhft7489895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002020","LU1781817850.SGD","LU0405327494.USD","LU1720050803.USD","BK0239","BK0188","LU0405327148.USD","HEXmain","LU1064131003.USD","BK0028","LU1328615791.USD","LU2495084118.USD","06030","LU1255011170.USD","BK1521","LU1146622755.USD","BK1564","LU2289578879.USD","LU2148510915.USD","LU1064130708.USD","600030","BK0012","BK0183","BK0276","LU1580142542.USD","BK0196","BK1516","IPOS","LU1655091616.SGD","LU1997245177.USD","LU1794554557.SGD","LU1820825898.SGD","LU2580892862.HKD","LU1997244956.HKD","BK1147","LU1997245094.SGD","LU2580892789.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157831","title":"2026年上半年业绩双降，京新药业二度递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157831","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669157831?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:11","pubTimestamp":1789985471,"startTime":"0","endTime":"0","summary":"从目前的业绩表现来看，2023年至2025年其营收几乎原地踏步，毛利率出现下滑；2026年上半年，该公司营收、净利润出现双降。税务处罚阴影除了业绩表现出现停滞甚至下滑，在递表港交所的过程中，京新药业的一项合规瑕疵受到市场关注。这一金额主要包括2021年至2023年的补充企业所得税约1080万元、过往年度最终结算调整约160万元，以及前述少缴的企业所得税约100万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789985380753917426","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IPOS","002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646154","title":"京新药业（002020）披露H股发行上市申请资料更新进展，9月21日股价上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669646154?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983376,"startTime":"0","endTime":"0","summary":"截至2026年9月21日收盘，京新药业报收于11.75元，较前一交易日上涨3.07%，最新总市值为101.17亿元。京新药业当日发布公告称，公司已于2026年2月11日向香港联交所递交H股发行上市申请，并于2026年9月18日更新递交申请材料，同日在香港联交所网站刊发更新后的申请资料。公司本次发行上市尚需获得中国证监会、香港证监会及香港联交所等监管机构的批准，存在不确定性。公司不会在境内媒体刊登该资料，但提供香港联交所网站链接供查阅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668185790","title":"京新药业：LP（a）降脂药临床II期正常推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2668185790","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668185790?lang=zh_cn&edition=full","pubTime":"2026-09-20 17:27","pubTimestamp":1789896430,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月20日在投资者关系平台上答复投资者关心的问题。投资者提问：诺华Lp(a)临床失败，会影响公司该产品正在进行的II期临床？公司是否对临床结果还有信心？京新药业回复：您好!公司LP（a）降脂药临床II期正常推进中。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000007434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668018575","title":"京新药业：盐酸卡立哌嗪已上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2668018575","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668018575?lang=zh_cn&edition=full","pubTime":"2026-09-20 17:27","pubTimestamp":1789896428,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月20日在投资者关系平台上答复投资者关心的问题。投资者提问：问吕董，重磅新药盐酸卡立哌嗪获批近三个月了，为什么还不上市销售，而且公司官网都没有？这效率也太低了吧？京新药业回复：您好，盐酸卡立哌嗪已上市销售。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000007431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668853401","title":"京新药业：更新递交H股发行上市申请并刊发申请资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2668853401","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668853401?lang=zh_cn&edition=full","pubTime":"2026-09-20 16:30","pubTimestamp":1789893000,"startTime":"0","endTime":"0","summary":"每经AI快讯，9月20日，京新药业公告称，公司正在推进申请发行境外上市股份(H股)并在香港联交所主板挂牌上市相关工作，此前已于2026年2月11日向香港联交所递交发行上市申请并刊登申请材料。2 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260920/c680092595.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260920/c680092595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141360209","title":"京新药业向港交所重新递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1141360209","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141360209?lang=zh_cn&edition=full","pubTime":"2026-09-20 16:29","pubTimestamp":1789892948,"startTime":"0","endTime":"0","summary":"京新药业宣布，公司已向香港联合交易所递交了更新后的上市申请文件。此举标志着这家制药企业在资本市场的布局再度迈出关键一步。公司此番动作，被市场解读为持续推进国际化融资战略的重要信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668232900","title":"本周3家港股公司招股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668232900","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668232900?lang=zh_cn&edition=full","pubTime":"2026-09-20 12:53","pubTimestamp":1789879980,"startTime":"0","endTime":"0","summary":"据利弗莫尔证券显示，本周（9月14日-9月20日）有一家公司向港交所递表，另有两家公司通过聆讯，3家公司招股。具体来看，9月18日，京新药业（002020.SZ）向港交所主板递交上市申请书。据招股 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20260920/c680089518.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260920/c680089518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["002020","603650","BK0239","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671207","title":"京新药业：公司JX2201降脂药目前处在临床II期","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667671207?lang=zh_cn&edition=full","pubTime":"2026-09-16 11:38","pubTimestamp":1789529898,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问诺华事件对公司降脂创新药的影响，是否会暂停二期临床京新药业回复：您好！公司JX2201降脂药目前处在临床II期，也会积极跟进最新的研发数据结果。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600014774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671242","title":"京新药业：公司会做好盐酸卡立哌嗪的上市销售工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671242","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667671242?lang=zh_cn&edition=full","pubTime":"2026-09-16 11:38","pubTimestamp":1789529888,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：给贵公司提个建议：卡利哌嗪未来开始铺货的话首选就近的医院也就是浙江省内的医院比较好，我不太了解商业化的东西，只是认为就近的话成本可控，医院和患者的使用感受能更快的传导到公司为公司全面铺货奠定基础，祝一切顺利京新药业回复：您好！谢谢您的建议。公司会做好盐酸卡立哌嗪的上市销售工作，为公司贡献营收。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600014763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665431416","title":"9月7日京新药业（002020）龙虎榜数据：机构净卖出1.1亿元，北向资金净买入7.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665431416","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665431416?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:52","pubTimestamp":1788774779,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月7日公布的交易公开信息显示，京新药业因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月7日收盘，京新药业报收于11.84元，下跌6.62%，换手率5.62%，成交量40.7万手，成交额4.84亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出1.1亿元，北向资金合计净买入7.87万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390288","title":"京新药业跌6.62% 西部证券今日刚维持买入评级就跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390288","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665390288?lang=zh_cn&edition=full","pubTime":"2026-09-07 16:15","pubTimestamp":1788768907,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 今日，京新药业(002020.SZ)收报11.84元，跌幅6.62%。\r\n\r\n　　西部证券股份有限公司研究员李梦园、邓琳茜于今日发布研报《京新药业(002020)2026年中报点评：地达西尼加速放量 仿创结合、产品矩阵持续丰富》称，基于公司地达西尼加速放量、创新管线稳步推进，维持“买入”评级。\r\n\r\n　　(责任编辑：魏京婷)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260907/32362070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002020","002673"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664342336","title":"京新药业：地达西尼的销量2026年二季度环比一季度有增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2664342336","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664342336?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:28","pubTimestamp":1788517699,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月04日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在5月分的时候说过地达西尼一季度销量同比环比上涨，也就是说一季度最少卖了8500万以上，上半年的销量1.53亿，请问二季度销量环比下跌的原因是什么？京新药业回复：您好！地达西尼的销量2026年二季度环比一季度有增长，2026年上半年累计销售额1.53亿元。公司会努力推进地达西尼的销售。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400035208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791828447914,"stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":0.0354},{"period":"3month","weight":-0.2057},{"period":"6month","weight":-0.2609},{"period":"1year","weight":-0.3881},{"period":"ytd","weight":-0.3668}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江京新药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"504人(较上一季度减少98.47%)","perCapita":"0股","listingDate":"2004-07-15","address":"浙江省绍兴市新昌县羽林街道新昌大道东路800号","registeredCapital":"86102万元","survey":"　　浙江京新药业股份有限公司的主营业务是化学制剂、传统中药、生物制剂、化学原料药、医疗器械的研发、生产及销售。公司的主要产品是化学制剂、中成药、生物制剂、化学原料药、医疗器械。公司为国家重点高新技术企业。","listedPrice":10.05},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"京新药业(002020)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供京新药业(002020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"京新药业,002020,京新药业股票,京新药业股票老虎,京新药业股票老虎国际,京新药业行情,京新药业股票行情,京新药业股价,京新药业股市,京新药业股票价格,京新药业股票交易,京新药业股票购买,京新药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"京新药业(002020)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供京新药业(002020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}